Investors flee Bayer after second Roundup trial blow The threat to German chemical giant Bayer and subsidiary Monsanto from US litigation swelled today, when its share price plunged after a jury ruled weedkiller Roundup was a "substantial factor" in a man's cancer. Business • 20 Mar 19
Investors flee Bayer after second Roundup trial blow The threat to German chemical giant Bayer and subsidiary Monsanto from US litigation swelled today, when its share price plunged after a jury ruled weedkiller Roundup was a "substantial factor" in a man's cancer. Business • 20 Mar 19
150,000 smear tests held up in NHS backlog A audit of cancer screening in England has found that not one NHS screening programme – including those for bowel, breast or cervical cancer – met their targets last year. Health • 01 Feb 19
150,000 smear tests held up in NHS backlog A audit of cancer screening in England has found that not one NHS screening programme – including those for bowel, breast or cervical cancer – met their targets last year. Health • 01 Feb 19
Pfizer forecasts 2019 revenue and profit below targets Pfizer has today forecast 2019 profit and sales below Wall Street estimates as it expects to take a blow from a stronger dollar and as well as the loss of patent on its blockbuster pain treatment Lyrica this year. Business • 29 Jan 19
Pfizer forecasts 2019 revenue and profit below targets Pfizer has today forecast 2019 profit and sales below Wall Street estimates as it expects to take a blow from a stronger dollar and as well as the loss of patent on its blockbuster pain treatment Lyrica this year. Business • 29 Jan 19
3D nipple tattoo helps woman after mastectomy A tattoo artist from Co Kildare says she is "empowering" cancer survivors by providing them with inkings to cover their mastectomy scars. News Lens • 23 Jan 19
3D nipple tattoo helps woman after mastectomy A tattoo artist from Co Kildare says she is "empowering" cancer survivors by providing them with inkings to cover their mastectomy scars. News Lens • 23 Jan 19
Eli Lilly buys Loxo Oncology in $8 billion cancer push Eli Lilly said today it would buy Loxo Oncology for about $8 billion in cash, buying into a portfolio of targeted medicines to treat cancers caused by rare gene mutations. Business • 07 Jan 19
Eli Lilly buys Loxo Oncology in $8 billion cancer push Eli Lilly said today it would buy Loxo Oncology for about $8 billion in cash, buying into a portfolio of targeted medicines to treat cancers caused by rare gene mutations. Business • 07 Jan 19
All cervical cancer patients to get experimental drug The Clinical Director of the National Centre for Pharmacoeconomics has said the experimental drug Pembrolizumab (Pembro) will be made available to all women suffering from cervical cancer under a "managed access programme". Health • 20 Dec 18
All cervical cancer patients to get experimental drug The Clinical Director of the National Centre for Pharmacoeconomics has said the experimental drug Pembrolizumab (Pembro) will be made available to all women suffering from cervical cancer under a "managed access programme". Health • 20 Dec 18
Bowel cancer research to lead to better outcomes Better analysis of bowel cancer tumours could produce improved outcomes for patients, researchers said. Health • 17 Dec 18
Bowel cancer research to lead to better outcomes Better analysis of bowel cancer tumours could produce improved outcomes for patients, researchers said. Health • 17 Dec 18
High Court judge warns of volume of cancer cases A High Court judge has warned that people who have sued over alleged delays in cancer diagnosis and alleged misdiagnosis may have passed away before their cases are heard. Courts • 29 Nov 18
High Court judge warns of volume of cancer cases A High Court judge has warned that people who have sued over alleged delays in cancer diagnosis and alleged misdiagnosis may have passed away before their cases are heard. Courts • 29 Nov 18
CUH breast cancer team 'demoralised' over scan delays A team of breast cancer consultants and specialist nurses at Cork University Hospital have clashed with senior management over services at the hospital. Health • 27 Nov 18
CUH breast cancer team 'demoralised' over scan delays A team of breast cancer consultants and specialist nurses at Cork University Hospital have clashed with senior management over services at the hospital. Health • 27 Nov 18
No other cases in review of genetic test transcriptions Our Lady's Children's Hospital in Crumlin has said that its review following an error in communicating a genetic test for an adult in 2009 has found no further cases. Health • 23 Nov 18
No other cases in review of genetic test transcriptions Our Lady's Children's Hospital in Crumlin has said that its review following an error in communicating a genetic test for an adult in 2009 has found no further cases. Health • 23 Nov 18
Trinity scientists develop therapy to treat rare cancer A new therapy that may hold potential for treating a rare soft-tissue cancer that most commonly affects young people has been developed by scientists at Trinity College Dublin. Science and Technology • 20 Nov 18
Trinity scientists develop therapy to treat rare cancer A new therapy that may hold potential for treating a rare soft-tissue cancer that most commonly affects young people has been developed by scientists at Trinity College Dublin. Science and Technology • 20 Nov 18
Crumlin reviewing 3,500 genetic test transcriptions Our Lady's Children's Hospital in Dublin is conducting a precautionary review of around 3,500 transcriptions of BRCA genetic test results, due to what it believes was a transcribing error with one test result. Health • 20 Nov 18
Crumlin reviewing 3,500 genetic test transcriptions Our Lady's Children's Hospital in Dublin is conducting a precautionary review of around 3,500 transcriptions of BRCA genetic test results, due to what it believes was a transcribing error with one test result. Health • 20 Nov 18
Calls for drug to be made available to cancer patients Labour's Health spokesperson Alan Kelly has called for a cancer drug currently available to the 221 women affected by the CervicalCheck controversy to be made available to all cancer patients who require it. Health • 15 Nov 18
Calls for drug to be made available to cancer patients Labour's Health spokesperson Alan Kelly has called for a cancer drug currently available to the 221 women affected by the CervicalCheck controversy to be made available to all cancer patients who require it. Health • 15 Nov 18
Husband wants answers after wife dies from cancer The husband of a 60-year-old woman who died last month following a cervical cancer diagnosis says he wants more answers in relation to the CervicalCheck crisis. Ireland • 20 Nov 18
Husband wants answers after wife dies from cancer The husband of a 60-year-old woman who died last month following a cervical cancer diagnosis says he wants more answers in relation to the CervicalCheck crisis. Ireland • 20 Nov 18
US judge upholds Monsanto verdict but slashes award A US judge has upheld a jury verdict against Bayer subsidiary Monsanto in a historic case regarding the cancer danger of some of its weed killer products, but slashed the punitive damages award. World • 23 Oct 18
US judge upholds Monsanto verdict but slashes award A US judge has upheld a jury verdict against Bayer subsidiary Monsanto in a historic case regarding the cancer danger of some of its weed killer products, but slashed the punitive damages award. World • 23 Oct 18
Emma Mhic Mhathúna's funeral to pass Govt Buildings Emma Mhic Mhathúna's funeral tomorrow will pass by Leinster House, Government Buildings, and the Department of Health, her family has said. Ireland • 09 Oct 18
Emma Mhic Mhathúna's funeral to pass Govt Buildings Emma Mhic Mhathúna's funeral tomorrow will pass by Leinster House, Government Buildings, and the Department of Health, her family has said. Ireland • 09 Oct 18
Harris pledges to build programme 'worthy of Emma' Minister for Health Simon Harris has pledged to "work to build a programme worthy of women like Emma" after the mother of five died of cancer at the age of 37. Health • 07 Oct 18
Harris pledges to build programme 'worthy of Emma' Minister for Health Simon Harris has pledged to "work to build a programme worthy of women like Emma" after the mother of five died of cancer at the age of 37. Health • 07 Oct 18
Trial to test whether aspirin can prevent cancer return Hundreds of Irish patients are about to take part in an international clinical trial to test whether aspirin can be used to prevent early stage cancer from returning. Cancer • 23 Sep 18
Trial to test whether aspirin can prevent cancer return Hundreds of Irish patients are about to take part in an international clinical trial to test whether aspirin can be used to prevent early stage cancer from returning. Cancer • 23 Sep 18
Harris still plans to have CervicalCheck commission Minister for Health Simon Harris has said he still plans to set up a Commission of Investigation into the CervicalCheck crisis despite the author of the review into the controversy saying he did not think one was needed. CervicalCheck • 11 Sep 18
Harris still plans to have CervicalCheck commission Minister for Health Simon Harris has said he still plans to set up a Commission of Investigation into the CervicalCheck crisis despite the author of the review into the controversy saying he did not think one was needed. CervicalCheck • 11 Sep 18
BBC presenter Rachael Bland dies from cancer aged 40 BBC news presenter Rachael Bland has died after being diagnosed with incurable cancer, her family has announced. Rachael Bland • 05 Sep 18
BBC presenter Rachael Bland dies from cancer aged 40 BBC news presenter Rachael Bland has died after being diagnosed with incurable cancer, her family has announced. Rachael Bland • 05 Sep 18
Bayer shares plunge 14% after Roundup cancer trial Shares in Bayer have plunged more than 14% to their lowest in almost five years - wiping around $14 billion off the value of the company - after a California jury ordered the German company's subsidiary Monsanto to pay $289m in damages last week. Business • 13 Aug 18
Bayer shares plunge 14% after Roundup cancer trial Shares in Bayer have plunged more than 14% to their lowest in almost five years - wiping around $14 billion off the value of the company - after a California jury ordered the German company's subsidiary Monsanto to pay $289m in damages last week. Business • 13 Aug 18
Trial may treat prostate cancer in fewer visits A radical new radiotherapy trial could significantly cut the number of visits for men with prostate cancer, researchers have said. Prostate cancer • 08 Aug 18
Trial may treat prostate cancer in fewer visits A radical new radiotherapy trial could significantly cut the number of visits for men with prostate cancer, researchers have said. Prostate cancer • 08 Aug 18
Australia scientists develop melanoma blood test Australian researchers said they have developed a blood test for melanoma in its early stages, calling it a "world first" breakthrough that could save many lives. Science and Technology • 18 Jul 18
Australia scientists develop melanoma blood test Australian researchers said they have developed a blood test for melanoma in its early stages, calling it a "world first" breakthrough that could save many lives. Science and Technology • 18 Jul 18
J&J ordered to pay $4.7 billion in asbestos cancer case A US jury has ordered Johnson & Johnson to pay a record $4.69 billion to 22 women who alleged the company's talc-based products, including its baby powder, contain asbestos and caused them to develop ovarian cancer. Business • 13 Jul 18
J&J ordered to pay $4.7 billion in asbestos cancer case A US jury has ordered Johnson & Johnson to pay a record $4.69 billion to 22 women who alleged the company's talc-based products, including its baby powder, contain asbestos and caused them to develop ovarian cancer. Business • 13 Jul 18
